NARI

Inari Medical, Inc.

Healthcare

Set alert

Price alert · NARI

All alert types
79.97 0.00 0.00%
As of Feb 18, 2025
79.96 Day range 79.97

52-week range unavailable

YTD
+56.65%
1 year
+41.87%
Open
79.96
Prev close
79.97
Mkt cap
4.68B
Vol
2.36M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
79.96
High
79.97
Forward P/E
571.21
Beta
1.03
Short ratio
0.54
Inst. own
95.56%
Dividend
0.00
Ex-div date
Earnings
Feb 28, 2024
50-d avg
70.53
200-d avg
53.51
1y target
78.03

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NARI has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

11.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2254×
FY 2018: -185×FY 2019: -1073×FY 2020: 203×FY 2021: 456×FY 2022: -116×FY 2023: -2254×
FY 2018 5y median -116× FY 2023
P/S 7.5×
FY 2018: 280×FY 2019: 40.1×FY 2020: 20.0×FY 2021: 16.4×FY 2022: 8.8×FY 2023: 7.5×
FY 2018 5y median 16.4× FY 2023
P/B 7.9×
FY 2018: -48.4×FY 2019: -52.3×FY 2020: 14.0×FY 2021: 19.0×FY 2022: 8.1×FY 2023: 7.9×
FY 2018 5y median 8.1× FY 2023
P/FCF 124×
FY 2018: -164×FY 2019: -253×FY 2020: -788×FY 2021: 384×FY 2022: -140×FY 2023: 124×
FY 2018 5y median -140× FY 2023
EV/EBITDA 242×
FY 2018: -211×FY 2019: 5966×FY 2020: 164×FY 2021: 293×FY 2022: -177×FY 2023: 242×
FY 2018 5y median 242× FY 2023
EV/Sales 7.5×
FY 2018: 278×FY 2019: 40.0×FY 2020: 19.2×FY 2021: 16.2×FY 2022: 8.7×FY 2023: 7.5×
FY 2018 5y median 16.2× FY 2023
FCF Yield 0.8%
FY 2018: -0.6%FY 2019: -0.4%FY 2020: -0.1%FY 2021: 0.3%FY 2022: -0.7%FY 2023: 0.8%
FY 2018 5y median -0.1% FY 2023

Profitability

Gross Margin 88.0%
FY 2018: 81.2%FY 2019: 88.4%FY 2020: 90.6%FY 2021: 91.1%FY 2022: 88.4%FY 2023: 88.0%
FY 2018 5y median 88.4% FY 2023
Operating Margin -2.8%
FY 2018: -133.8%FY 2019: 1.6%FY 2020: 13.2%FY 2021: 2.4%FY 2022: -7.3%FY 2023: -2.8%
FY 2018 5y median 1.6% FY 2023
Net Margin -0.3%
FY 2018: -148.7%FY 2019: -3.7%FY 2020: 9.9%FY 2021: 3.6%FY 2022: -7.6%FY 2023: -0.3%
FY 2018 5y median -0.3% FY 2023
ROE -0.4%
FY 2018: 25.7%FY 2019: 4.9%FY 2020: 6.9%FY 2021: 4.1%FY 2022: -7.0%FY 2023: -0.4%
FY 2018 5y median 4.1% FY 2023
ROIC 0.9%
FY 2018: -36.9%FY 2019: 2.2%FY 2020: 9.2%FY 2021: 2.3%FY 2022: -6.3%FY 2023: 0.9%
FY 2018 5y median 2.2% FY 2023
ROA -0.2%
FY 2018: -37.7%FY 2019: -4.3%FY 2020: 6.4%FY 2021: 3.2%FY 2022: -5.8%FY 2023: -0.2%
FY 2018 5y median -0.2% FY 2023

Growth (YoY)

Revenue 28.7%
FY 2018: 0.0%FY 2019: 648.7%FY 2020: 173.2%FY 2021: 98.3%FY 2022: 38.4%FY 2023: 28.7%
FY 2018 FY 2023
Operating Income 50.1%
FY 2018: 0.0%FY 2019: 108.8%FY 2020: 2198.1%FY 2021: -63.8%FY 2022: -521.1%FY 2023: 50.1%
FY 2018 FY 2023
EPS (diluted) 94.8%
FY 2018: 0.0%FY 2019: 82.8%FY 2020: 781.8%FY 2021: -33.3%FY 2022: -405.6%FY 2023: 94.8%
FY 2018 FY 2023
Free Cash Flow 224.3%
FY 2018: 0.0%FY 2019: 30.6%FY 2020: 56.1%FY 2021: 433.7%FY 2022: -302.0%FY 2023: 224.3%
FY 2018 FY 2023

Financial Health

Current Ratio 3.1×
FY 2018: 12.2×FY 2019: 4.4×FY 2020: 14.9×FY 2021: 5.8×FY 2022: 7.5×FY 2023: 3.1×
FY 2018 5y median 5.8× FY 2023
Quick Ratio 2.5×
FY 2018: 11.7×FY 2019: 4.0×FY 2020: 14.1×FY 2021: 5.3×FY 2022: 6.9×FY 2023: 2.5×
FY 2018 5y median 5.3× FY 2023
Debt / Equity 0.1×
FY 2018: -0.2×FY 2019: -0.5×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×
FY 2018 5y median 0.1× FY 2023
Net Debt / EBITDA -0.4×
FY 2018: 1.3×FY 2019: -12.1×FY 2020: -7.0×FY 2021: -4.2×FY 2022: 1.5×FY 2023: -0.4×
FY 2018 5y median -4.2× FY 2023
Interest Coverage -71.6×
FY 2018: -10.3×FY 2019: 0.9×FY 2020: 16.2×FY 2021: 22.6×FY 2022: -95.6×FY 2023: -71.6×
FY 2018 5y median 0.9× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31